1RIECHELMANN H.Immunotherapy with allergen extracts for allergic rhinitis[J].HNO,2005,53:517-530.
2OHASHI Y,NAKAI Y,TANAKA A,et al.Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts[J].Acta Otolaryngol Suppl,1998,538:113-117.
3VAN REE R,CHAPMAN M D,FERREIRA F,et al.The CREATE project:development of certified reference materials for allergenic products and validation of methods for their quantification[J].Allergy,2008,63:310-326.
6CANONICA G W,BAENA-CAGNANI C E,BOUSQUET J,et al.Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy.A statement of a World Allergy Organization(WAO) taskforce[J].Allergy,2007,62:317-324.
7WHEELER A W,DRACHENBERG K J.New routes and formulations for allergen-specific immunotherapy[J].Allergy,1997,52:602-612.
8PLATTS-MILLS T A,MUELLER G A,WHEATLEY L M.Future directions for allergen immunotherapy[J].J Allergy Clin Immunol,1998,102:335-343.
10SRIVASTAVA D,SINGH B P,ARORA N,et al.Clinico-immunologic study on immunotherapy with mixed and single insect allergens[J].J Clin Immunol,2009,29:665-673.
7La Rosa M, Ranno C, Andre C, et al. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol, 1999, 104:425-432.
8Bousquet J, Scheinmann P, Guinnepain MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy,1999, 54: 249-260.
9Smith H, White P, Annila I, et al. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol, 2004,114 : 831-837.
10Bahcecilier NN, Arikan C, Taylor A, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mite. Int Arch Allergy Immunol, 2005, 136:287 -294.
6Krilis S, Baldo BA, Basten A. Antigens and allergens from the common house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol, 1984,74 (2) : 142-146.
7Bousquet J, Lockey R, Mailing HJ, et al. Allergen immunotherapy:therapeutic vaccines for allergic diseases. World Heaith Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol,1998,81 (5 pt 1 ) :401-405.
8(EAACI) The European Academy of Allergology and Clinical Immuno logy. Positior Paper: Immuntherapy with hymenoptera venoms. Allerry, 1993,48 ( 14 suppl) :36-46.
